%0 Journal Article
%T Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
%A Andrej Jane£¿
%A Andrej Jureti£¿
%A Miha Japelj
%A Miodrag Jani£¿
%A Mi£¿o £¿abovi£¿
%A Mojca Lunder
%J Archive of "Cardiovascular Diabetology".
%D 2018
%R 10.1186/s12933-018-0797-6
%X Patient characteristics in study groups at inclusion in the study (before) and after 12 weeks of treatment (after) with empagliflozin 25 mg daily (EMPA), metformin 2000 mg daily (MET), empagliflozin/metformin (EMPA/MET) or placebo (PLACEBO
%K Empagliflozin
%K Metformin
%K Empagliflozin/metformin
%K Vascular protection
%K Arterial stiffness
%K Endothelial function
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276165/